Which airway device seals better during laparoscopic surgery?
NCT ID NCT07692139
First seen Jul 09, 2026 · Last updated Jul 22, 2026 · Updated 3 times
Summary
This study compares two supraglottic airway devices — the i-gel and the SaCoVLM — in adults having elective laparoscopic gallbladder removal. Researchers will measure how well each device seals the airway, how easily it is inserted, and any complications. The goal is to see which device provides safer and more effective ventilation during this type of surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If one device performs better, it could guide anesthesiologists in choosing a safer, more effective airway tool for similar surgeries.
- What could go wrong
- This is a small observational study, not a randomized trial, so results may not apply broadly. Differences between devices may be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of adult patients aged 18-70 years with American Society of Anesthesiologists (ASA) physical status I-III who are scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia at Samsun City Hospital. Eligible patients who provide written informed consent and meet the study inclusion criteria will be consecutively enrolled during the study period.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 70 years. * American Society of Anesthesiologists (ASA) physical status I-III. * Patients scheduled for elective laparoscopic cholecystectomy. * Patients undergoing general anesthesia. * Patients who provide written informed consent. Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End tidal carbon dioxide are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Noninvasive perioperative hemodynamic monitoring in thoracic surgery: a prospective observational study
- Could a neck vein check replace a harder ultrasound for ICU fluid management?
- Could a heart monitor during surgery shield patients from hidden cardiac harm?
- Can Computer-Controlled sedation reduce breathing risks during spine surgery?
- New dashboard aims to give surgeons a complete view during heart surgery
- Breath of life: CO2 readings may predict cardiac arrest survival